Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : True face of China -- A Modern Kaleidoscope -- Ignore unavailable to you. Want to Upgrade?

To: RealMuLan who wrote (600)	11/14/2006 11:31:22 PM
From: RealMuLan	Read Replies (1) \| Respond to of 12464

" Forget BRICs, Here Come The New MCS By Bill billakanodoodahs.com For now, at least, you can forget 75% of the old BRIC axiom. The current hot foreign plays are the “New MCs” – Mexico, China, and Spain. Spain? ...

To: RealMuLan who wrote (600)	11/15/2006 1:45:28 PM
From: hui zhou	Read Replies (1) \| Respond to of 12464

American Oriental Bio Hits 52-Week High Wednesday November 15, 1:14 pm ET American Oriental Bioengineering Shares Hit New 52-Week High After Doubling 3rd-Quarter Profit NEW YORK (AP) -- Shares of American Oriental Bioengineering Inc. rose to a new 52-week high Wednesday after the China-based maker of herbal supplements reported that profit and revenue more than doubled for the third quarter. ADVERTISEMENT American Oriental Bioengineering shares rose $1.22, or 14.5 percent, to $9.65 in afternoon trading on the American Stock Exchange at more than three times their average volume. Shares, which hit a high of $9.84 earlier in the session, have traded between $4.10 and $8.55 over the past 52 weeks. The company reported late Tuesday that net earnings rose to $7.6 million, or 12 cents per share, from $3.7 million, or 8 cents per share, and that revenue more than doubled to $27.1 million from $13.4 million a year ago. American Oriental Bioengineering forecast earnings per share for the year of at least 45 cents on revenue of $106 million to $108 million. Brean Murray Carret analyst Julie Chen, who rates the company a "Buy," raised her earnings estimate to 45 cents per share from 41 cents for 2006, and to 58 cents from 49 cents for 2007. Chen is one of the two analysts who covers the company. Chen said in a note that the company's television advertising campaign proved to be effective, resulting in the strong sales performance.